Diffusion MRI in Heart Failure
Part of paid clinical trials in Charlestown, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT02973633
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Heart Failure
- Left Ventricular Hypertrophy
- Myocardial Infarction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- Diffusion Tensor MRI (DTI) — DEVICEDiffusion Tensor MRI (DTI) measures the diffusion of water in the heart, which allows the orientation of the muscle fibers in the heart to be determined.
- Gadolinium DOTA Meglumine — DRUGLate Gadolinium enhancement
Study Details
The development of symptomatic heart failure is frequently preceded by a pre-clinical period of structural remodeling in the heart. The remodeling process driving this transition, however, remains poorly understood. The investigators hypothesize that imaging the diffusion of water in the heart with MRI will allow its microstructure to be resolved. The investigators further hypothesize that the characterization of microstructural changes in the heart will help elucidate the pathogenesis of heart failure and the transition from a compensated to a decompensated state. Patients with recent myocardial infarcts and left ventricular hypertrophy, who are at risk for the development of heart failure, will be enrolled. The participants will undergo serial diffusion tensor MRI (DTI) imaging of the heart to characterize changes in myocardial microstructure over time.
Key Dates
- Start date
- Jun 30, 2017
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Active Comparator: Healthy VolunteersDTI will be performed in healthy volunteers to characterize normal fiber architecture in the heart and provide a comparison group for the patients imaged in the other arms.
- Active Comparator: Patients with Recent Myocardial InfarctionPatients with recent ST elevation myocardial infarcts will be recruited and imaged serially with DTI to detect changes in fiber architecture and their correlation with remodeling of the left ventricle.
- Active Comparator: Patients with Left Ventricular HypertrophyPatients with left ventricular hypertrophy and a history of heart failure will be recruited and imaged serially with DTI to detect changes in fiber architecture and their correlation with the onset and progression of heart failure.
Primary Outcome Measure
Myofiber Helix Angle [ Time Frame: 12 months ]
Central Contacts
- David E. Sosnovik, MD617-724-3407
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Charlestown | Massachusetts | 02129 | - |
Find similar trials in Charlestown, MA
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Home Hospital for Suddenly Ill AdultsRecruiting · Brigham and Women's Hospital · Boston, Massachusetts